Ignite Creation Date:
2024-05-06 @ 2:29 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02054351
Status:
COMPLETED
Last Update Posted:
2021-11-10
First Post:
2014-01-29
Brief Title:
Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer OVAR
Sponsor:
Ganymed Pharmaceuticals GmbH
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
GM-IMAB-002-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ganymed Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None